Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
426.45
258.21
154.08
80.94
42.22
29.35
16.99
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
426.45
258.21
154.08
80.94
42.22
29.35
16.99
Raw Material Cost
207.29
170.00
119.53
80.48
62.01
40.35
43.04
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
13.93
25.03
19.28
13.06
11.99
8.99
5.52
Selling and Distribution Expenses
78.37
63.29
70.30
55.19
39.22
28.08
26.41
Other Expenses
-1.21
-2.17
-1.55
-0.92
-0.61
-0.66
-0.16
Total Expenditure (Excl Depreciation)
287.47
236.58
193.66
139.56
107.13
70.77
73.37
Operating Profit (PBDIT) excl Other Income
139
21.6
-39.6
-58.6
-64.9
-41.4
-56.4
Other Income
1.90
1.33
-0.59
-0.22
0.16
12.10
0.07
Operating Profit (PBDIT)
148.93
31.29
-33.05
-53.33
-60.81
-26.07
-52.87
Interest
13.93
25.03
19.28
13.06
11.99
8.99
5.52
Exceptional Items
-1.24
-26.17
-6.67
0.00
0.99
-9.96
-3.90
Gross Profit (PBDT)
219.16
88.22
34.55
0.46
-19.79
-11.00
-26.05
Depreciation
8.04
8.33
7.11
5.50
3.94
3.26
3.45
Profit Before Tax
125.71
-28.24
-66.12
-71.89
-75.75
-48.28
-65.74
Tax
-71.96
0.00
-0.21
-0.24
0.00
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
197.67
-28.24
-65.90
-71.65
-75.75
-48.28
-65.74
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
197.67
-28.24
-65.90
-71.65
-75.75
-48.28
-65.74
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
197.67
-28.24
-65.90
-71.65
-75.75
-48.28
-65.74
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
349.02
135.21
151.97
141.17
88.25
26.19
19.77
Earnings per share (EPS)
0.81
-0.13
-0.33
-0.51
-0.88
-0.89
-1.45
Diluted Earnings per share
0.81
-0.13
-0.33
-0.51
-0.88
-0.89
-1.45
Operating Profit Margin (Excl OI)
32.59%
8.38%
-25.69%
-72.41%
-153.75%
-141.14%
-331.99%
Gross Profit Margin
31.37%
-7.71%
-38.29%
-82.02%
-170.08%
-153.4%
-366.77%
PAT Margin
46.35%
-10.94%
-42.77%
-88.52%
-179.41%
-164.5%
-387.06%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is 65.18% vs 67.55% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is 801.06% vs 57.21% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is 390.00% vs 192.31% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is -44.40% vs 29.53% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has improved from Dec 2023
Compare Annual Results Of ADMA Biologics, Inc. With
Figures in Million
Consolidate Annual Results
Change(USD)
Change(%)
Net Sales
426.45
6.24
420.21
6,734.13%
Other Operating Income
0.00
0.00
0.00
Total Operating income
426.45
6.24
420.21
6,734.13%
Raw Material Cost
207.29
0.41
206.88
50,458.54%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
13.93
0.00
13.93
Selling and Distribution Expenses
78.37
24.58
53.79
218.84%
Other Expenses
-1.21
8.31
-9.52
-114.56%
Total Expenditure (Excl Depreciation)
287.47
108.10
179.37
165.93%
Operating Profit (PBDIT) excl Other Income
138.98
-101.86
240.84
236.44%
Other Income
1.90
16.89
-14.99
-88.75%
Operating Profit (PBDIT)
148.93
-84.56
233.49
276.12%
Interest
13.93
0.00
13.93
Exceptional Items
-1.24
0.00
-1.24
Gross Profit (PBDT)
219.16
5.82
213.34
3,665.64%
Depreciation
8.04
0.41
7.63
1,860.98%
Profit Before Tax
125.71
-84.97
210.68
247.95%
Tax
-71.96
0.00
-71.96
Provisions and contingencies
0
0
0.00
Profit After Tax
197.67
-84.97
282.64
332.64%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
197.67
-84.97
282.64
332.64%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
197.67
-84.97
282.64
332.64%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
349.02
352.48
-3.46
-0.98%
Earnings per share (EPS)
0.81
-2.55
3.36
131.76%
Diluted Earnings per share
0.81
-2.55
3.36
131.76%
Operating Profit Margin (Excl OI)
32.59%
-1,633.74%
0.00
1,666.33%
Gross Profit Margin
31.37%
-1,356.17%
0.00
1,387.54%
PAT Margin
46.35%
-1,362.77%
0.00
1,409.12%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 42.65 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 65.18% vs 67.55% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 19.77 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 801.06% vs 57.21% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 14.70 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 390.00% vs 192.31% in Dec 2023
Annual - Interest
Interest 1.39 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -44.40% vs 29.53% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 32.59%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has improved from Dec 2023
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
